Outbreak of metabolic dysfunction-associated steatohepatitis pharmacotherapies in 2024: From resmetirom to tirzepatide

被引：0
|
作者：
Huang Rui [1 ]
Zhang Chunli [2 ]
Mo Xiaodong [3 ]
Rao Huiying [1 ]
机构：
[1] Peking University People’s Hospital, Peking University Hepatology Institute, Infectious Disease and Hepatology Center of Peking University People’s Hospital, Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, Beijing International
[2] Department of Hematology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China
[3] Peking University People’s Hospital, Department of Hematology, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing,
来源：
中华医学杂志英文版 | 2025年 / 138卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R575.5 [肝代谢障碍];
学科分类号：
摘要：
<正>
引用
收藏
相关论文
共 50 条
  • [1] Outbreak of metabolic dysfunction-associated steatohepatitis pharmacotherapies in 2024: From resmetirom to tirzepatide
    Huang, Rui
    Zhang, Chunli
    Mo, Xiaodong
    Rao, Huiying
    CHINESE MEDICAL JOURNAL, 2025, 138 (02) : 127 - 129
  • [2] Resmetirom (Rezdiffra) for Metabolic Dysfunction-Associated Steatohepatitis
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2024, 66 (1701):
  • [3] Tirzepatide for Metabolic Dysfunction-Associated Steatohepatitis with Liver Fibrosis
    Loomba, Rohit
    Hartman, Mark L.
    Lawitz, Eric J.
    Vuppalanchi, Raj
    Boursier, Jerome
    Bugianesi, Elisabetta
    Yoneda, Masato
    Behling, Cynthia
    Cummings, Oscar W.
    Tang, Yuanyuan
    Brouwers, Bram
    Robins, Deborah A.
    Nikooie, Amir
    Bunck, Mathijs C.
    Haupt, Axel
    Sanyal, Arun J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (04): : 299 - 310
  • [4] Resmetirom: Breakthrough therapeutic approach for metabolic dysfunction-associated steatohepatitis
    Saeed, Anzel
    Rai, Kuldeep Dalpat
    Saeed, Muzammil
    LIVER RESEARCH, 2024, 8 (03) : 193 - 194
  • [5] Resmetirom for metabolic dysfunction-associated steatohepatitis: targeting hepatic and cardiovascular disease
    Lurje, Isabella
    Tacke, Frank
    HEPATOBILIARY SURGERY AND NUTRITION, 2024, 13 (06) : 1034 - 1037
  • [6] A 4-week mouse model allows the rapid evaluation of resmetirom and tirzepatide benefits on metabolic dysfunction-associated steatohepatitis
    Briand, Francois
    Breyner, Natalia
    Grasset, Estelle
    Sulpice, Thierry
    JOURNAL OF HEPATOLOGY, 2024, 80 : S597 - S598
  • [7] Metabolic Dysfunction-Associated Steatohepatitis and Cardiovascular Disease Prevention: Is Resmetirom Useful?
    Borozan, Sanja
    Vujosevic, Snezana
    Mikhailidis, Dimitri P.
    Muzurovic, Emir
    CURRENT VASCULAR PHARMACOLOGY, 2025, 23 (01) : 4 - 7
  • [8] Resmetirom and Metabolic Dysfunction-Associated Steatohepatitis: Perspectives on Multidisciplinary Management from Global Healthcare Professionals
    Au, Kahei
    Zheng, Ming-Hua
    Lee, Wei-Jei
    Ghanem, Omar M.
    Mahawar, Kamal
    Shabbir, Asim
    le Roux, Carel W.
    Targher, Giovanni
    Byrne, Christopher D.
    Yilmaz, Yusuf
    Valenti, Luca
    Sebastiani, Giada
    Treeprasertsuk, Sombat
    Hui, Hannah Xiaoyan
    Sakran, Nasser
    Neto, Manoel Galvao
    Kermansaravi, Mohammad
    Kow, Lilian
    Seki, Yosuke
    Tham, Kwang Wei
    Dang, Jerry
    Cohen, Ricardo V.
    Stier, Christine
    Alsabah, Salman
    Oviedo, Rodolfo J.
    Chiappetta, Sonja
    Parmar, Chetan
    Yang, Wah
    CURRENT OBESITY REPORTS, 2024, 13 (04): : 818 - 830
  • [9] Tirzepatide for treatment of metabolic dysfunction-associated steatohepatitis: relationship between metabolic and histological responses
    Caussy, C.
    Hartman, M. L.
    Thomas, M. K.
    Mather, K. J.
    Tang, Y.
    Loomba, R.
    Sanyal, A. J.
    DIABETOLOGIA, 2024, 67 : S121 - S121
  • [10] Resmetirom, the first approved drug for the management of metabolic dysfunction-associated steatohepatitis: Trials, opportunities, and challenges
    Kokkorakis, Michail
    Boutari, Chrysoula
    Hill, Michael A.
    Kotsis, Vasilios
    Loomba, Rohit
    Sanyal, Arun J.
    Mantzoros, Christos S.
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2024, 154
12345